PMEL and melanoma: IFN-β, but not IFN-α, was shown to increase mRNA and protein expression of melanocytic tumor-associated antigens (Melan-A/MART-1, gp100, MAGE-A1) in 15 melanoma cell lines, inducing susceptibility to lysis by cytotoxic T lymphocytes [67].